Overview of combined hormonal contraception
- an estrogen—estetrol, estradiol (or its prodrug estradiol valerate), ethinylestradiol or mestranol
- a progestogen—cyproterone, desogestrel, dienogest, drospirenone, etonogestrel, gestodene, levonorgestrel, nomegestrol or norethisterone.
Combined hormonal contraceptives primarily work by suppressing ovulation; they also cause thickening of cervical mucus.
COCs and vaginal rings are equivalent in effectiveness, contraindications and precautions, drug interactions and adverse effects. The vaginal ring can be a useful option if a nonoral method of combined hormonal contraception is preferred, or if unscheduled bleeding occurs with the COC. See Comparison of combined oral contraceptives and the contraceptive vaginal ring for a comparison of the COC and the vaginal ring.
Characteristic |
Combined oral contraceptive |
Contraceptive vaginal ring |
---|---|---|
daily action required |
yes; compliance errors possible at any time |
no, but compliance errors can occur with insertion of a new ring (risk of breakthrough ovulation is highest at the end of the hormone-free interval) |
effectiveness |
93% with typical use 99.5% with perfect use |
93% with typical use 99.5% with perfect use |
absorption affected by vomiting, severe diarrhoea or malabsorption |
yes |
no |
breakthrough bleeding |
more frequent than with vaginal ring |
less frequent than with COC (superior cycle control) |
device-related symptoms and problems |
none |
may cause increased physiological vaginal discharge or discomfort may be accidentally expelled self-insertion may be unacceptable |
cost |
some formulations available on PBS |
not available on PBS |
Note:
COC = combined oral contraceptive; PBS = Pharmaceutical Benefits Scheme Modified with permission from: Contraception: an Australian clinical practice handbook. 4th ed. Ashfield, New South Wales: Family Planning New South Wales, Family Planning Victoria, and True Relationships and Reproductive Health; 2016. |